Similarly, a VHL-targeting antibody applied to lysates from MG132-treated ccRCC (786-O) cells stably reconstituted with HA-VHL, specifically co-precipitated pRb as compared to an isotype control (Supplementary Fig. S1B). Here, VHL is linked to nonpapillary renal cell carcinoma.